Shilpa Medicare Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Shilpa Medicare.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 17.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
What Shilpa Medicare Limited's (NSE:SHILPAMED) 27% Share Price Gain Is Not Telling You
Apr 12Shilpa Medicare Limited's (NSE:SHILPAMED) Shares Climb 28% But Its Business Is Yet to Catch Up
Feb 21Shilpa Medicare (NSE:SHILPAMED) Takes On Some Risk With Its Use Of Debt
Jan 02These 4 Measures Indicate That Shilpa Medicare (NSE:SHILPAMED) Is Using Debt Extensively
Jul 17Shilpa Medicare (NSE:SHILPAMED) Seems To Be Using A Lot Of Debt
Mar 17Increases to CEO Compensation Might Be Put On Hold For Now at Shilpa Medicare Limited (NSE:SHILPAMED)
Sep 22Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10
Sep 07Shilpa Medicare's (NSE:SHILPAMED) Dividend Will Be ₹1.10
Aug 14Here's Why Shilpa Medicare (NSE:SHILPAMED) Is Weighed Down By Its Debt Load
Jan 27Shareholders May Not Be So Generous With Shilpa Medicare Limited's (NSE:SHILPAMED) CEO Compensation And Here's Why
Sep 21Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?
Jun 17If You Like EPS Growth Then Check Out Shilpa Medicare (NSE:SHILPAMED) Before It's Too Late
May 31Shilpa Medicare Limited's (NSE:SHILPAMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Mar 07Shilpa Medicare Limited (NSE:SHILPAMED) Analysts Are Reducing Their Forecasts For Next Year
Feb 20Does Shilpa Medicare (NSE:SHILPAMED) Have A Healthy Balance Sheet?
Jan 26Here's Why I Think Shilpa Medicare (NSE:SHILPAMED) Is An Interesting Stock
Jan 14Shilpa Medicare (NSE:SHILPAMED) Shareholders Have Enjoyed A 54% Share Price Gain
Jan 03Could The Shilpa Medicare Limited (NSE:SHILPAMED) Ownership Structure Tell Us Something Useful?
Dec 22Is There More To The Story Than Shilpa Medicare's (NSE:SHILPAMED) Earnings Growth?
Dec 11How Much Are Shilpa Medicare Limited (NSE:SHILPAMED) Insiders Taking Off The Table?
Nov 30How Is Shilpa Medicare's (NSE:SHILPAMED) CEO Compensated?
Nov 16Earnings Release: Here's Why Analysts Cut Their Shilpa Medicare Limited (NSE:SHILPAMED) Price Target To ₹611
Nov 04In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Shilpa Medicare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2024 | 11,516 | 319 | -492 | 1,353 | N/A |
12/31/2023 | 11,248 | -7 | N/A | N/A | N/A |
9/30/2023 | 11,008 | -119 | -30 | 2,523 | N/A |
6/30/2023 | 10,491 | -321 | N/A | N/A | N/A |
3/31/2023 | 10,517 | -325 | -464 | 2,262 | N/A |
12/31/2022 | 11,286 | 51 | N/A | N/A | N/A |
9/30/2022 | 11,384 | 213 | -1,605 | 1,666 | N/A |
6/30/2022 | 11,693 | 599 | N/A | N/A | N/A |
3/31/2022 | 11,469 | 607 | -2,267 | 1,051 | N/A |
12/31/2021 | 10,135 | 395 | N/A | N/A | N/A |
9/30/2021 | 9,324 | 376 | -2,589 | 478 | N/A |
6/30/2021 | 9,156 | 631 | N/A | N/A | N/A |
3/31/2021 | 9,016 | 1,478 | -3,073 | 469 | N/A |
12/31/2020 | 9,135 | 1,739 | N/A | N/A | N/A |
9/30/2020 | 9,591 | 2,213 | -2,704 | 793 | N/A |
6/30/2020 | 9,698 | 2,267 | N/A | N/A | N/A |
3/31/2020 | 9,082 | 1,562 | -2,249 | 1,244 | N/A |
12/31/2019 | 8,876 | 1,455 | N/A | N/A | N/A |
9/30/2019 | 8,241 | 1,029 | -3,065 | 819 | N/A |
6/30/2019 | 6,962 | 944 | N/A | N/A | N/A |
3/31/2019 | 7,337 | 1,123 | -1,532 | 1,468 | N/A |
12/31/2018 | 7,693 | 1,193 | N/A | N/A | N/A |
9/30/2018 | 7,814 | 1,281 | N/A | N/A | N/A |
6/30/2018 | 8,211 | 1,167 | N/A | N/A | N/A |
3/31/2018 | 7,894 | 1,052 | -931 | 449 | N/A |
12/31/2017 | 7,756 | 1,133 | N/A | N/A | N/A |
9/30/2017 | 7,731 | 1,149 | N/A | N/A | N/A |
6/30/2017 | 7,787 | 1,190 | N/A | N/A | N/A |
3/31/2017 | 7,795 | 1,076 | N/A | 375 | N/A |
12/31/2016 | 7,565 | 1,048 | N/A | N/A | N/A |
9/30/2016 | 7,735 | 1,153 | N/A | N/A | N/A |
6/30/2016 | 7,369 | 1,024 | N/A | N/A | N/A |
3/31/2016 | 7,166 | 1,083 | N/A | 1,287 | N/A |
12/31/2015 | 6,867 | 886 | N/A | N/A | N/A |
9/30/2015 | 6,430 | 776 | N/A | N/A | N/A |
6/30/2015 | 6,234 | 728 | N/A | N/A | N/A |
3/31/2015 | 6,138 | 737 | N/A | 688 | N/A |
12/31/2014 | 6,145 | 731 | N/A | N/A | N/A |
9/30/2014 | 6,143 | 798 | N/A | N/A | N/A |
6/30/2014 | 5,966 | 787 | N/A | N/A | N/A |
3/31/2014 | 5,714 | 757 | N/A | 700 | N/A |
12/31/2013 | 5,025 | 664 | N/A | N/A | N/A |
9/30/2013 | 4,422 | 556 | N/A | N/A | N/A |
6/30/2013 | 3,965 | 536 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SHILPAMED's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if SHILPAMED's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if SHILPAMED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SHILPAMED's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if SHILPAMED's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SHILPAMED's Return on Equity is forecast to be high in 3 years time